2 unknown. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
| Phase 2 | 1 | Unknown 1 |
Follow Filariasis: new trials by email Literature Review of Filariasis trials Research Report on Filariasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A 3- to 5-day Clinical Trial of Levamisole in Loiasis Infected Subjects Levamisole 3 days, Levamisole 5 days, Placebo - Loiasis | Phase 2 / Phase 3 | Unknown | Programme National de Lutte contre l'Onchocercose, Republic of the Congo | 99 | 2024-06-21 | 2024-09-20 |
| Adjunctive Ivermectin Mass Drug Administration for Malaria Control Ivermectin, Placebo, Dihydroartemisinin-piperaquine - Malaria,Falciparum, Neglected Tropical Diseases | Phase 3 | Unknown | London School of Hygiene and Tropical Medicine | 24000 | 2021-05-03 | 2022-02-24 |
Ancylostomiasis (1) · Elephantiasis, Filarial (1) · Loiasis (1) · Malaria (1) · Malaria, Falciparum (1) · Neglected Diseases (1) · Onchocerciasis (1) · Scabies (1) · Strongyloidiasis (1)
Helminthiasis (2) · Infections (2) · Nematode Infections (2) · Parasitic Diseases (2) · Secernentea Infections (2) · Skin Diseases (2) · Skin Diseases, Infectious (2) · Skin Diseases, Parasitic (2) · Skin and Connective Tissue Diseases (2) · Spirurida Infections (2) · Disease Attributes (1) · Ectoparasitic Infestations (1) · Hemic and Lymphatic Diseases (1) · Hookworm Infections (1)
Ivermectin (1) · Levamisole (1)
London School of Hygiene and Tropical Medicine (1) · Programme National de Lutte contre l'Onchocercose, Republic of the Congo (1)
Guinea-Bissau (1) · Republic of the Congo (1)